Search research articles
Contact Us
Filters
Showing results (181-190 of 343) with videos related to
Page
of 35
Sort By:
Cancer Chemotherapy and Pharmacology
|
July 2, 2015
Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma
David Fogelman, Elizabeth A Sugar, George Oliver, et al.
Annals of Surgical Oncology
|
June 27, 2023
NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma
Shishir K Maithel, Jessica M Keilson, Hop S Tran Cao, et al.
Journal of Gastroenterology and Hepatology
|
September 21, 2006
Akt expression may predict favorable prognosis in cholangiocarcinoma
Milind M Javle, Jihnhee Yu, Thaer Khoury, et al.
JAMA Network Open
|
May 6, 2024
KRAS Allelic Variants in Biliary Tract Cancers
Gordon Taylor Moffat, Zishuo Ian Hu, Funda Meric-Bernstam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2019
Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic Cancer
Jennifer B Goldstein, Li Zhao, Xuemei Wang, et al.
Practical Radiation Oncology
|
March 29, 2014
Gastric bleeding after radiation therapy for intrahepatic cholangiocarcinoma
Prajnan Das, Mirna T Abboud, Waqar Haque, et al.
Cancer Discovery
|
September 23, 2021
Futibatinib, an Irreversible FGFR1-4 Inhibitor, in Patients with Advanced Solid Tumors Harboring <i>FGF</i>/<i>FGFR</i> Aberrations: A Phase I Dose-Expansion Study
Funda Meric-Bernstam, Rastislav Bahleda, Cinta Hierro, et al.
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma
Timothy P DiPeri, Mehmet Demirhan, Daniel D Karp, et al.
Cancer
|
December 17, 2016
Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients
Suguru Yamashita, Eugene Jon Koay, Guillaume Passot, et al.
Cancer Investigation
|
February 25, 2009
Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis
Milind M Javle, Gary Yang, Chumy E Nwogu, et al.
Page
of 35
Search research articles
Search
Showing results (181-190 of 343) with videos related to
Sort By:
Page
of 35
Cancer Chemotherapy and Pharmacology
|
July 2, 2015
Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma
David Fogelman, Elizabeth A Sugar, George Oliver, et al.
Annals of Surgical Oncology
|
June 27, 2023
NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma
Shishir K Maithel, Jessica M Keilson, Hop S Tran Cao, et al.
Journal of Gastroenterology and Hepatology
|
September 21, 2006
Akt expression may predict favorable prognosis in cholangiocarcinoma
Milind M Javle, Jihnhee Yu, Thaer Khoury, et al.
JAMA Network Open
|
May 6, 2024
KRAS Allelic Variants in Biliary Tract Cancers
Gordon Taylor Moffat, Zishuo Ian Hu, Funda Meric-Bernstam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2019
Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic Cancer
Jennifer B Goldstein, Li Zhao, Xuemei Wang, et al.
Practical Radiation Oncology
|
March 29, 2014
Gastric bleeding after radiation therapy for intrahepatic cholangiocarcinoma
Prajnan Das, Mirna T Abboud, Waqar Haque, et al.
Cancer Discovery
|
September 23, 2021
Futibatinib, an Irreversible FGFR1-4 Inhibitor, in Patients with Advanced Solid Tumors Harboring <i>FGF</i>/<i>FGFR</i> Aberrations: A Phase I Dose-Expansion Study
Funda Meric-Bernstam, Rastislav Bahleda, Cinta Hierro, et al.
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma
Timothy P DiPeri, Mehmet Demirhan, Daniel D Karp, et al.
Cancer
|
December 17, 2016
Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients
Suguru Yamashita, Eugene Jon Koay, Guillaume Passot, et al.
Cancer Investigation
|
February 25, 2009
Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis
Milind M Javle, Gary Yang, Chumy E Nwogu, et al.
Page
of 35